Systemic delivery of bictegravir and tenofovir alafenamide using dissolving microneedles for HIV preexposure prophylaxis

[Display omitted] Human immunodeficiency virus (HIV) continues to pose a serious threat to global health. Oral preexposure prophylaxis (PrEP), considered highly effective for HIV prevention, is the utilisation of antiretroviral (ARV) drugs before HIV exposure in high-risk uninfected individuals. How...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of pharmaceutics 2024-07, Vol.660, p.124317, Article 124317
Hauptverfasser:	Zhang, Chunyang, Wu, Yu, Hutton, Aaron R.J., Hidayat Bin Sabri, Akmal, Hobson, James J., Savage, Alison C., McCarthy, Helen O, Paredes, Alejandro J., Owen, Andrew, Rannard, Steven P., Donnelly, Ryan F.
Format:	Artikel
Sprache:	eng
Schlagworte:	Bictegravir Human immunodeficiency virus Microneedles Nanoparticles Tenofovir alafenamide
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!